0001181431-12-007506.txt : 20120209 0001181431-12-007506.hdr.sgml : 20120209 20120209185556 ACCESSION NUMBER: 0001181431-12-007506 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120207 FILED AS OF DATE: 20120209 DATE AS OF CHANGE: 20120209 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hung David CENTRAL INDEX KEY: 0001310880 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32836 FILM NUMBER: 12588890 MAIL ADDRESS: STREET 1: 501 SECOND STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94107 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEDIVATION, INC. CENTRAL INDEX KEY: 0001011835 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133863260 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 201 SPEAR STREET, 3RD FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 BUSINESS PHONE: 415-543-3470 MAIL ADDRESS: STREET 1: 201 SPEAR STREET, 3RD FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 FORMER COMPANY: FORMER CONFORMED NAME: ORION ACQUISITION CORP II DATE OF NAME CHANGE: 19960408 4 1 rrd333558.xml 2/7/12 SALES X0304 4 2012-02-07 0 0001011835 MEDIVATION, INC. MDVN 0001310880 Hung David C/O MEDIVATION, INC. 201 SPEAR STREET, 3RD FLOOR SAN FRANCISCO CA 94105 1 1 0 0 President and CEO Common Stock 2012-02-07 4 S 0 4800 70.30 D 1209474 D Common Stock 2012-02-07 4 S 0 14500 71.21 D 1194974 D Common Stock 2012-02-07 4 S 0 23971 72.22 D 1171003 D Common Stock 2012-02-07 4 S 0 100 73.01 D 1170903 D Common Stock 2012-02-07 4 S 0 100 73.23 D 1170803 D Common Stock 2012-02-08 4 S 0 22000 68.40 D 1148803 D Common Stock 2012-02-08 4 S 0 28400 69.22 D 1120403 D Common Stock 2012-02-08 4 S 0 4700 70.38 D 1115703 D Common Stock 2012-02-08 4 S 0 1429 71.56 D 1114274 D Common Stock 86060 I By Trust Shares sold pursuant to a 10b5-1 Plan. The shares were sold at prices between $69.77 and $70.77. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices between $70.775 and $71.76. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices between $71.78 and $72.53. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices between $67.80 and $68.80. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices between $68.81 and $69.80. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices between $69.81 and $70.80. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices between $71.22 and $71.88. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. /s/ C. Patrick Machado, Attorney-in-fact 2012-02-09